Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Bronchopulmonary NETs (BPNETs) exhibit indolent to aggressive behavior. Imaging, histology and biochemistry are limited in accurately defining malignancy or progression. A blood based NET multigene test is effective in diagnosing GEP-NET progression and therapy response.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Kidd M
Authors: Lewczuk A, Chung K, Kolasińska-Ćwikła A, Ćwikła J, Kidd M,
Keywords: NET,
#1881 A Gene Expression-Based Nomogram Predicts Progression Free Survival in Small Bowel NETs
Introduction: Nomograms are predictive tools that help prognosticate. A survival nomogram has been validated for small bowel NETs. A circulating NET specific 51gene signature – the NETest – has efficacy (~95%) as a predictor of progression free survival (PFS).
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Kidd M
Authors: Kidd M, Tesselaar M, Korse T, Verbeek W, Drozdov I,
Keywords: Nomogram, prognosis, NETest, PFS, grade, biomarker,
Introduction: Everolimus (EVE) is an approved treatment for progressive well-differentiated pNENs and usually induces stable disease. Until now, there is no reliable biomarker for the response to EVE.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Lock A
Authors: Lock A, Wirtz R, Kaemmerer D, Haugvik S, Kure E,
Keywords: PREDICT-Study, everolimus, pNEN, gene signature, predictive marker,
#1497 Circulating Neuroendocrine Tumor Gene Signature, the NETest, Defines Therapy in GEP-NETs
Introduction: Early and precise delineation of therapeutic responses are key issues in GEP-NET management. Imaging has limitations in sensitivity while secretory biomarkers e.g., CgA is controversial.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Kolasinska-Cwikla A
Authors: Kolasińska-Ćwikła A, Cwikła J, Bodei L, Sankowski A, Drozdov I,
Introduction: The CgA has limitations as a monoanalyte biomarker. The introduction of a PCR-based multi-analyte analysis of 51 genes (NETest) has been proposed as more accurate.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Tesselaar M, Korse T, Kidd M, Verbeek W, Drozdov I,
Keywords: NETest, CgA, PCR, progressive disease,